Publications by authors named "M Fiol"
Background: Approximately 5% to 10% of patients who undergo kidney transplantation develop ureteral stricture, which can be treated endoscopically or by open surgery, which is more effective but complications are common and potentially severe. Robotic surgery has begun to emerge as an alternative in reconstructive procedures. However, few studies have evaluated the role of robotic surgery in this clinical setting.
View Article and Find Full Text PDFBackground And Aims: Moderate wine consumption has been associated with lower cardiovascular disease (CVD) risk in older populations. However, wine consumption information through self-reports is prone to measurement errors inherent to subjective assessments. The aim of this study was to evaluate the association between urinary tartaric acid, an objective biomarker of wine consumption, and the rate of a composite clinical CVD event.
View Article and Find Full Text PDFBackground: Leukocyte telomere length (LTL) shortens with age and may be related to multiple sclerosis (MS).
Objective: We hypothesize that chronologically young people with MS (pwMS) with short LTL behave similarly to older MS subjects.
Methods: Prospective 2-year study including two cohorts of young (18-35 years) and elderly (⩾50 years) pwMS with similar disease duration.
Article Synopsis
- Susac syndrome, multiple sclerosis, and primary angiitis of the central nervous system often present similar symptoms, making accurate diagnosis a challenge; the study aimed to improve this through a new scoring system called the SPAMS score.
- The research involved 99 patients from South America and utilized an elastic-net model to determine important MRI features for distinguishing between these conditions.
- The SPAMS score demonstrated high diagnostic accuracy, effectively differentiating SuS from MS and PACNS, highlighting the importance of specific MRI findings for timely interventions and potentially better patient outcomes.
Background: Immunosuppressive therapies as azathioprine (AZA), mycophenolate mofetil (MMF) and rituximab (RTX) are widely prescribed as first-line treatment to prevent relapses in NMOSD. However, the rate of response to these traditional therapies is unknown in Argentina. We aimed to describe and compare treatment failure rates in NMOSD patients included in the Argentinean MS and NMOSD registry (RelevarEM, NCT03375177).
View Article and Find Full Text PDF